Virus particles were reassembled in vitro from tomato aspermy virus strain V (V-TAV) RNA and a mixture of subunits prepared from V-TAV and 3~S-labelled cucumber mosaic virus strain T (T-CMV). Immunodiffusion tests showed that the reassembled particles reacted with polyclonal antisera raised against both V-TAV and T-CMV. Radioactivity was found in the precipitin line formed between the reassembled particles and antiserum raised against T-CMV as well as in the precipitin line formed between the reassembled particles and antiserum raised against V-TAV. This shows that 35S-labelled T-CMV protein subunits were incorporated with V-TAV protein subunits into the same particles. Thus, coat proteins of V-TAV and T-CMV can coassemble and form mixed-subunit capsids in vitro.The coat protein subunits of two cucumoviruses, cucumber mosaic virus (CMV) and tomato aspermy virus (TAV), can encapsidate each other's RNA in vitro, as well as the RNA of tobacco mosaic virus (Chen & Francki, 1990). Since the particle structures of cucumoviruses and the molecular masses of their coat protein subunits are similar (Francki, 1985; Palukaitis et al., 1992), the question arises as to whether coat protein subunits of two different cucumoviruses can combine in the same capsid to produce a particle with a mixedsubunit capsid. In this paper, we show that particles comprising coat protein subunits of both TAV (strain V, V-TAV) and CMV (strain T, T-CMV) can assemble in vitro.To label T-CMV coat protein, 2.5 mCi ~5SO~-(in 1 ml of aqueous solution; Amersham) was applied directly to the roots of Nicotiana clevelandii plants infected with T-CMV and showing the first signs of systemic symptoms (5-7 days post-inoculation). The plants were then kept under continuous light for 6-8 days (Hajimorad, 1989). Unlabelled T-CMV and V-TAV were propagated in N. clevelandii in the glasshouse. Both the labelled and unlabelled viruses were purified as described previously (Francki et al., 1979) and the viral RNAs were isolated by phenol extraction (Peden & Symons, 1973 T-CMV protein was prepared from 1,5 mg T-CMV (0"3 mg 35S-labelled virus mixed with 1.2 mg unlabelled virus). V-TAV protein was prepared from 1.5 mg of V-TAV. T-CMV protein and V-TAV protein (each 0.7 mg) were mixed with 0.35 mg of V-TAV RNA in a total volume of 3-32 ml. The mixture was dialysed against assembly buffer (20 mM-Tris-HC1 pH 7.2, containing 80 mM-KC1, 1 mM-DTT and 1 mM-MgC12) for 16 h at 4 °C (Chen& Francki, 1990). The mixture was analysed by sucrose density gradient centrifugation. Virus preparations were examined in a JEM 100CX electron microscope after staining with 1% uranyl acetate (Hatta & Francki, 1984). The antiserum raised against T-CMV was previously cross-absorbed with V-TAV by adding 1 mg of the virus to 1 ml of the antiserum, incubating at room temperature for 3 h, and pelleting the virusantiserum complex by centrifugation at 370000g for 15 min. This cross-absorption procedure was done twice. The antiserum raised against V-TAV was cross-absorbed with T-CMV by the same method...